Accelerated apoptosis in the Timp-3-deficient mammary gland

被引:88
作者
Fata, JE
Leco, KJ
Voura, EB
Yu, HYE
Waterhouse, P
Murphy, G
Moorehead, RA
Khokha, R [1 ]
机构
[1] Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
[2] GlycoDesign, Toronto, ON, Canada
[3] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
关键词
D O I
10.1172/JCI13171
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The proapoptotic proteinase inhibitor TIMP-3 is the only molecule of this family thought to influence cell death. We examined epithelial apoptosis in TIMP-3-deficient mice during mammary gland involution. Lactation was not affected by the absence of TIMP-3, but glandular function, as measured by gland-to-body weight ratio and production of beta -casein, was suppressed earlier during post-lactational involution than in controls. Histological examination revealed accelerated lumen collapse, alveolar-epithelial loss, and adipose reconstitution in Timp-3(-/-) females. Epithelial apoptosis peaked on the first day of involution in Timp-3-null glands but at day 3 in wild-type littermates. Unscheduled activation of gelatinase-A was evident by zymography and correlated with earlier fragmentation of fibronectin in Timp-3(-/-) mammary. To obtain independent evidence of the proapoptotic effects of TIMP-3 deficiency, we introduced recombinant TIMP-3-releasing pellets into regressing Timp-3(-/-) mammary tissue and showed that this treatment rescued lumen collapse and epithelial apoptosis. Ex vivo, involuting Timp-3(-/-) mammary tissue demonstrated accelerated epithelial apoptosis that could be reduced by metalloproteinase inhibition. The physiological relevance of TIMP-3 became apparent as Timp-3(-/-) dams failed to reestablish lactation after brief cessation of suckling. Thus, TIMP-3 is a critical epithelial survival factor during mammary gland involution.
引用
收藏
页码:831 / 841
页数:11
相关论文
共 70 条
[21]   Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3 [J].
George, SJ ;
Lloyd, CT ;
Angelini, GD ;
Newby, AC ;
Baker, AH .
CIRCULATION, 2000, 101 (03) :296-304
[22]  
Gomez DE, 1997, EUR J CELL BIOL, V74, P111
[23]   Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor [J].
Hargreaves, PG ;
Wang, FF ;
Antcliff, J ;
Murphy, G ;
Lawry, J ;
Graham, R ;
Russell, G ;
Croucher, PI .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (04) :694-702
[24]  
Ilic D, 1998, J CELL BIOL, V143, P547
[25]  
Kang SH, 2000, INT J CANCER, V86, P632, DOI 10.1002/(SICI)1097-0215(20000601)86:5<632::AID-IJC5>3.0.CO
[26]  
2-5
[27]   Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125FAK levels plus proteoglycan-mediated apoptosis via caspases [J].
Kapila, YL ;
Wang, SH ;
Johnson, PW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30906-30913
[28]   TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5) [J].
Kashiwagi, M ;
Tortorella, M ;
Nagase, H ;
Brew, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12501-12504
[29]   Adamalysins -: A family of metzincins including TNF-α converting enzyme (TACE) [J].
Killar, L ;
White, J ;
Black, R ;
Peschon, J .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :442-452
[30]  
KIMATA K, 1985, J EMBRYOL EXP MORPH, V89, P243